Research on Magnetically Targeted Drug Delivery System Based on Fullerene Derivatives

被引:0
|
作者
Wang, Ying [1 ]
Su, Li [2 ]
Li, Bing [1 ]
Jin, Ningning [1 ]
Lu, Riji [3 ]
Zhang, Jing [1 ]
机构
[1] Zhengzhou Univ, Sch Chem & Energy Engn, 100 Sci Rd, Zhengzhou, Henan, Peoples R China
[2] Zhengzhou Third Peoples Hosp Lab, 1 Caishi St, Zhengzhou, Henan, Peoples R China
[3] Wei An Packaging Prod Co Ltd, 50 Meters West Jiangpu Rd,Suzhou Ind Pk, Suzhou, Jiangsu, Peoples R China
来源
MATERIALS SCIENCE-MEDZIAGOTYRA | 2021年 / 27卷 / 04期
关键词
carboxyl-terminated fullerene pyrrolidine; iron oxide; magnetic targeting; doxorubicin; PHOTODYNAMIC THERAPY; CONTROLLED-RELEASE; NANOPARTICLES; DOXORUBICIN; C-60;
D O I
10.5755/j02.ms.24918
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
A carboxyl-terminated fullerene pyrrolidine derivative was synthesized by 1, 3-dipolar cycloaddition of imine ylide (FPCOOH). UV-Vis, FT-IR and MALDI-TOF respectively verified the effective synthesis of compounds. The compound (FPCOOH) was used as an intermediate, and then the hydrothermal chemical bonding method was used to load ferric oxide on the compound (FP-COOH). Its purpose was to form a magnetic targeting carrier system (FP-IONP-COOH). Then use the non-covalent method to combine FP-IONP-COOH with doxorubicin. The ultimate goal was to improve the side effects of doxorubicin. The solubility experiments showed that both FP-IONP-COOH and FP-IONP-COOH/DOX had good water solubility. The investigation of magnetism showed that FP-IONP-COOH has good magnetism. Finally, in vitro release experiments further verified the targeting of FP-IONP-COOH/DOX. The cumulative release of DOX at 48 h could be as high as 82 %, whereas the accumulated release of FP-IONP-COOH/DOX at 48 h was only 48 %, and was able to release for more than 120 h, its sustained release in vivo.
引用
收藏
页码:444 / 450
页数:7
相关论文
共 50 条
  • [21] Magnetically Targeted Drug Delivery System through Imaging Technology PID Feedback Control, and MATLAB
    Saifullah, Faizan
    Inam, Hafsa
    Ali, Murtaza Najabat
    Ansari, Umar
    ICBBT 2019: 2019 11TH INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICAL TECHNOLOGY, 2019, : 142 - 148
  • [22] PEGylation of graphene/iron oxide nanocomposite: assessment of release of doxorubicin, magnetically targeted drug delivery and photothermal therapy
    Ramezani Farani, Marzieh
    Khadiv-Parsi, Parissa
    Hossein Riazi, Gholam
    Ardestani, Mehdi Shafiee
    Saligheh Rad, Hamidreza
    APPLIED NANOSCIENCE, 2020, 10 (04) : 1205 - 1217
  • [23] Three dimensional motion control system of ferromagnetic particles for magnetically targeted drug delivery systems
    Mishima, Fumihito
    Takeda, Shin-ichi
    Izumi, Yoshinobu
    Nishijima, Shigehiro
    IEEE TRANSACTIONS ON APPLIED SUPERCONDUCTIVITY, 2006, 16 (02) : 1539 - 1542
  • [24] A peptide-based pH-sensitive drug delivery system for targeted ablation of cancer cells
    Jin, Yulong
    Huang, Yanyan
    Yang, Hua
    Liu, Guoquan
    Zhao, Rui
    CHEMICAL COMMUNICATIONS, 2015, 51 (77) : 14454 - 14457
  • [25] Use of Materials Based on Polymeric Silica as Bone-Targeted Drug Delivery Systems for Metronidazole
    Czarnobaj, Katarzyna
    Prokopowicz, Magdalena
    Greber, Katarzyna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (06):
  • [26] Chitosan-based nanoparticles for tumor-targeted drug delivery
    Prabaharan, M.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2015, 72 : 1313 - 1322
  • [28] Preparation of multifunctional Janus nanoparticles on the basis of SPIONs as targeted drug delivery system
    Shaghaghi, Behrad
    Khoee, Sepideh
    Bonakdar, Shahin
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 559 : 1 - 12
  • [29] Intratumoral implantable drug delivery system for targeted localized chemotherapy in breast cancer
    Souri, Mohammad
    Elahi, Sohail
    Soltani, M.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2024, 94
  • [30] Inulin-based polymer coated SPIONs as potential drug delivery systems for targeted cancer therapy
    Scialabba, C.
    Licciardi, M.
    Mauro, N.
    Rocco, F.
    Ceruti, M.
    Giammona, G.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2014, 88 (03) : 695 - 705